
Loading, please wait...

Loading, please wait...

The landscape of mental health startup funding in India is evolving rapidly as digital solutions gain traction. Recently, the on-demand conversation platform HeyyPal secured an investment from Umesh Bhatt, an Abu Dhabi-based venture capitalist. This deal values the startup at Rs 20 crore, marking a significant milestone for the firm. Consequently, the infusion of capital will help scale their tech-enabled wellness services across the country.
Furthermore, this investment signals a rising interest among global investors in scalable healthcare technologies. HeyyPal provides a privacy-first platform that links users with verified psychiatrists, psychologists, and trained listeners. Because accessibility remains a primary concern in India, the platform utilizes per-minute consultations to lower cost barriers. Therefore, users can receive instant support without the traditional hurdles of scheduling or stigma.
Umesh Bhatt brings extensive technology expertise to this partnership. He currently serves as the Cluster Director of IT at hospitality major Rotana. Specifically, Bhatt highlighted that combining human empathy with technology makes HeyyPal a unique and impactful solution. Moreover, the founder, Vishwalok Nath, stated that the startup is now better positioned to accelerate growth and expand its reach.
Q1: Who is the primary investor in the latest HeyyPal funding round?
Umesh Bhatt, an Abu Dhabi-based venture capitalist and Cluster Director of IT at Rotana, provided the investment.
Q2: How does HeyyPal intend to improve mental healthcare accessibility?
The platform offers on-demand, per-minute consultations with verified professionals. This approach reduces costs and removes the stigma associated with seeking psychiatric help.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


HeyyPal, an Indian mental health platform, raised funding from Umesh Bhatt at a 20 crore valuation to scale its on-demand experts-led conversation platform....
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today